Probe of GSK has foreign firms in China worried

The continuing investigation of British drug giant GlaxoSmithKline (GSK) and China National Petroleum Corp (CNPC) along with its subsidiary PetroChina has added to worries that companies in China lack adequate protection against corruption investigations, says British risk consultancy Control Risks.

via Business feed http://www.scmp.com/business/companies/article/1307984/probe-gsk-has-foreign-firms-china-worried